Inactive Instrument
ViaDerma, Inc. Share Price Other OTC
Stocks
VDRM
US92555K1016
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 6.31M 5.46M 5.12M 4.67M 8.78M 601M 8.91M 60.2M 23.53M 301M 23.68M 23.16M 1B | P/E 2015 |
10.7x | P/E 2016 | -3.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.6M 5.72M 5.36M 4.89M 9.19M 630M 9.33M 63.04M 24.64M 315M 24.79M 24.25M 1.05B | EV / Sales 2015 |
1.5x | EV / Sales 2016 | 3.63x |
| Free-Float |
99% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | +5.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 30/03/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Ayo Otiko
CHM | Chairman | - | 30/03/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.85% | -24.07% | - | - | 247K | ||
| -1.60% | +0.86% | +3.70% | +14.41% | 48.72B | ||
| -0.14% | +4.03% | +482.13% | +584.43% | 43.99B | ||
| -0.06% | +9.62% | +24.63% | +81.63% | 40.82B | ||
| -0.87% | +2.40% | +30.01% | +9.95% | 39.79B | ||
| -4.04% | +6.15% | +23.03% | +48.00% | 32.7B | ||
| -1.41% | +1.57% | +29.98% | +123.68% | 16.66B | ||
| +0.35% | +4.61% | - | - | 16.84B | ||
| -0.43% | -0.11% | +4.22% | +20.83% | 13.95B | ||
| +0.84% | +9.07% | +86.17% | +32.60% | 13.58B | ||
| Average | -0.15% | +3.96% | +85.48% | +114.44% | 29.67B | |
| Weighted average by Cap. | -0.99% | +3.93% | +104.21% | +137.91% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 192K 166K 156K 142K 267K 18.29M 271K 1.83M 716K 9.16M 720K 704K 30.54M | 252K 218K 205K 187K 351K 24.03M 356K 2.41M 940K 12.03M 946K 926K 40.13M |
| Net income | 27.12K 23.5K 22.02K 20.08K 37.75K 2.59M 38.33K 259K 101K 1.3M 102K 99.62K 4.32M | -122K -106K -98.88K -90.19K -170K -11.62M -172K -1.16M -455K -5.82M -457K -447K -19.4M |
| Net Debt | 288K 250K 234K 213K 401K 27.49M 407K 2.75M 1.08M 13.77M 1.08M 1.06M 45.9M | 297K 257K 241K 220K 413K 28.31M 419K 2.83M 1.11M 14.17M 1.11M 1.09M 47.26M |
Employees
-
















